Physician profile

John J Molitor

Diagnostic Radiology · Corvallis, OR

NPI 1841258647

$608.52

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$113.82

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
W. L. Gore & Associates, INC. $261.10 2020-2022
Abbott Laboratories $96.28 2022
Medtronic, INC. $91.02 2021
Penumbra, INC. $77.20 2024 Indigo System
Janssen Pharmaceuticals, INC $23.45 2019
Bard Peripheral Vascular, INC. $22.85 2020
Cook Medical LLC $21.35 2023 Zilver Ptx
Inari Medical, INC. $15.27 2024 Ct Thrombectomy System Kit, Flowtriever Catheter, S

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

John J Molitor

$608.52

in general payments reported 2019-2025

Years
2019-2024
Top company
W. L. Gore & Associates, INC.

https://glasscript.com/doctor/220001/john-j-molitor

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.